Medtronic earns CE mark for Stealth AXiS robot platform in ENT surgery

Medtronic (NYSE:MDT) today announced the receipt of CE mark approval for its Stealth AXiS surgical system for ENT procedures.

Approval expands access to the company’s next-generation ear, nose and throat (ENT) navigation platform across Europe. It offers advanced visualization, navigation and connected workflow capabilities to ENT surgeons and hospitals.

Stealth AXiS combines familiar navigation workflows with a modular robotic design, the medtech giant says. It allows institutions to deploy what they need and expand over time as needs evolve. The company built the system on its existing Mazor and StealthStation technologies.

Sign up for Blog Updates